Faculty of Pharmacy at Manitoba Centre for Health Policy in Department of Community Health Sciences in Faculty of Medicine at University of Manitoba in Winnipeg. c_metge@umanitoba.ca
Manitoba, which maintains a comprehensive population-based repository of health care services provided and has a publicly funded health care system.
Women 50 years old and older who had suffered fractures between 1997 and 2002. These women were chosen from among approximately 175,000 women of this age in Manitoba.
We examined each woman's annual medical record between April 1, 1997, and March 31, 2002, to find any International Classification of Diseases fracture codes that have been consistently associated with osteoporosis. We looked for postfracture care during the first 12 months after fractures: bone mineral density (BMD) testing or treated with osteoporosis pharmacotherapy. Analysis was stratified by type of fracture: designated type 1 fractures (spine or hip) and type 2 fractures (not spine or hip).
Use of BMD testing or osteoporosis pharmacotherapy during the first 12 months following fractures.
For type 1 fractures, BMD assessment during the first year after fracture increased from 2.6% in 1997-1998 to 4.6% in 2001-2002 (P for trend .0004). Rates of therapy with osteoporosis medication increased from 4.9% in 1997-1998 to 17.6% in 2001-2002 (P for trend
Notes
Cites: Curr Med Res Opin. 2004 Apr;20(4):433-915119979
Cites: AJR Am J Roentgenol. 2004 Feb;182(2):297-30014736649